











































Optimising hospital electronic prescribing systems
Citation for published version:
Williams, J, Malden, S, Heeney, C, Bouamrane, M-M, Holder, M, Perera, U, Bates, DW & Sheikh, A 2021,
'Optimising hospital electronic prescribing systems: A Systematic Scoping Review', Journal of patient safety.
https://doi.org/10.1097/PTS.0000000000000867
Digital Object Identifier (DOI):
10.1097/PTS.0000000000000867
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of patient safety
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.







































Optimizing Hospital Electronic Prescribing Systems: A
Systematic Scoping Review
Jac Williams, MBChB,* Stephen Malden, PhD,* Catherine Heeney, PhD,* Matt Bouamrane, PhD,*
Mike Holder, MBChB,* Uditha Perera, MD,* David W. Bates, MD, MSc,† and Aziz Sheikh, MD*
Objective: Considerable international investment in hospital electronic pre-
scribing (ePrescribing) systems has been made, but despite this, it is proving
difficult for most organizations to realize safety, quality, and efficiency gains
in prescribing. The objective of this work was to develop policy-relevant in-
sights into the optimization of hospital ePrescribing systems to maximize the
benefits andminimize the risks of these expensive digital health infrastructures.
Methods: We undertook a systematic scoping review of the literature by
searching MEDLINE, Embase, and CINAHL databases. We searched for
primary studies reporting on ePrescribing optimization strategies and inde-
pendently screened and abstracted data until saturation was achieved. Find-
ings were theoretically and thematically synthesized taking a medicine
life-cycle perspective, incorporating consultative phases with domain experts.
Results: We identified 23,609 potentially eligible studies from which
1367 satisfied our inclusion criteria. Thematic synthesis was conducted
on a data set of 76 studies, of which 48 were based in the United States.
Key approaches to optimization included the following: stakeholder
engagement, system or process redesign, technological innovations,
and education and training packages. Single-component interventions
(n = 26) described technological optimization strategies focusing on a
single, specific step in the prescribing process. Multicomponent inter-
ventions (n = 50) used a combination of optimization strategies, typi-
cally targeting multiple steps in the medicines management process.
Discussion: We identified numerous optimization strategies for enhanc-
ing the performance of ePrescribing systems. Key considerations for
ePrescribing optimization include meaningful stakeholder engagement
to reconceptualize the service delivery model and implementing techno-
logical innovations with supporting training packages to simultaneously
impact on different facets of the medicines management process.
Key Words: patient safety, quality, efficiency, ePrescribing, health IT,
medicines management
(J Patient Saf 2021;00: 00–00)
I n most health systems globally, replacing traditional paper-basedprocesses and pathwayswith digital systems and services is now
considered a strategic priority to modernize and optimize the effi-
ciency and safety of healthcare. Previous implementation experi-
ences have highlighted that this is usually a complex long-term
process, involving multiple stakeholders, with different expec-
tations and priorities.1 Electronic prescribing (also known as com-
puterized physician order entry [CPOE] with or without
computerized decision support [CDS] and henceforth referred to
as ePrescribing) is an area of health-system digitization, which
can provide a range of benefits—from more efficient medication
ordering and administration processes to alerting, error preven-
tion, and improved patient safety.2 ePrescribing systems also have
the potential to promote prescriber adherence with evidence-based
guidelines, facilitate cost-conscious prescribing, and enable changes
in the medicines use process.3
Realizing the benefits of ePrescribing is largely dependent on
optimizing these systems, so that the available functionalities are
fully enabled, appropriately used, integrated with other relevant
health information technology (IT), and embedded with clinical
priorities and workflows. Substantial and cost-effective reductions
in clinically important medication errors can be achieved with the
implementation of ePrescribing systems, but these are not guaran-
teed. Successful deployment is contingent on the context of the
ePrescribing implementation, and the use of identical software
can lead to very different results in different hospitals, in part be-
cause these systems are highly configurable at the local level.4
ePrescribing systems are becoming increasingly complex, requir-
ing iterative development and commitment to a life-cycle perspec-
tive.5 Emergent research focuses on ensuring these large-scale and
expensive health IT infrastructures now deliver the promised clin-
ical improvements through the process of systems optimization.6
The aim of this work was to map the landscape of optimization
strategies within the field of hospital ePrescribing and develop an
evidence-informed policy-focused overview of the range of ap-
proaches that have been deployed to maximize the patient, pro-
vider, and organizational benefits of ePrescribing systems.
METHODS
Overview of Methods
We used the 6-stage framework proposed by Arksey and
O’Malley7 and then further refined by Levac et al8 to undertake
a systematic scoping review of the international literature. Our
methods are detailed in full in the published protocol and summa-
rized hereinafter.9 Embracing the iterative nature of conducting a
scoping protocol, a feature strongly endorsed by Levac et al,8 the
inclusion and exclusion criteria from the initial protocol have been
refined (Table 1). An essential requirement for included studies
was the implementation of an optimization strategy within an
ePrescribing system. Systems optimization was defined as “the
activity of enhancing system capabilities and integration of sub-
system elements to the extent that all components operate at or
above user expectations.”10 ePrescribing was defined as “the utili-
zation of electronic systems to facilitate and enhance the commu-
nication of a prescription or medicine order, aiding the choice,
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administration and supply of a medicine through knowledge and
decision support, and providing a robust audit trail for the entire
medicines use process.”11
Systematic Scoping Review
Abstracts and full texts were independently screened by 2 re-
viewers, with conflicts moderated by a third member of the re-
search team (J.W., S.M., C.H., M.B., M.H., U.P.). In view of the
substantial body of evidence uncovered, we decided to focus on
the most recently published articles using principles of data satu-
ration. Saturation is amethodological principle taken fromqualitative
research where it is mostly used as a criterion for discontinuing data
analysis or collection.12Although the concept of saturation still seems
to be evolving, we identify with the 2016 definition by Given,13 who
considered saturation as the point at which “additional data do not
lead to any new emergent themes.” This involved conducting
full-text screening (J.W., S.M., C.H., M.B.) and data extraction
(J.W., S.M., M.B.) where we added a code for every new optimi-
zation strategy encountered during extraction. It was agreed that
saturation would be achieved when no new codes emerged for op-
timization strategies from 10 consecutive studies.
Interpretation of Findings
Extracted data were synthesized by applying thematic analysis
to a theoretical approach that considered the medication manage-
ment life cycle and the propensity for errors at each stage of this
process.14 ePrescribing optimization strategies were then themati-
cally analyzed based on where the intervention lay within the
ePrescribing process (Fig. 1).
TABLE 1. Inclusion and Exclusion Criteria
Inclusion criteria
Primary studies or systematic reviews with a clearly defined
methodology that describe an approach/approaches that are
implemented to optimize an ePrescribing system.
The study must take part in a healthcare context that is applicable to
learning for UK NHS hospitals.
The study should be set in a high-income country, as defined by the
OECD.
Exclusion criteria
Study does not describe an optimization strategy implemented in an
ePrescribing system.
The study is an opinion piece or a review without a clearly defined
methodology.
Study takes place in a healthcare context that is not applicable to
learning for UK NHS hospitals.
The country of the study is not within the OECD.
OECD, Organization for Economic Co-operation and Development;
NHS, National Health Service.
FIGURE 1. Theoretical approach showing a conceptualization of the medicines use process and the various stages with potential for
optimization within an ePrescribing system.
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Consultative phases with domain experts and patient and pub-
lic involvement representatives were integrated throughout this
work. The feedback from 2 round-table events with international
and UK experts on ePrescribing, which took place in June 2019
and January 2020, were used to discuss and refine the thematic
synthesis applied to our results.
RESULTS
Included Studies
We identified 30,214 potentially eligible studies, which, after the
removal of duplicate studies, resulted in 23,609 studies eligible for
abstract screening. The abstract screening stage led to the identifica-
tion of an initial set of 1367 records eligible for full-text screening.
Studies were then screened and extracted in reverse chronological
order, with 817 studies not screened because of reaching data satu-
ration. Of the 550 studies screened, we excluded 336 leaving 214
included studies (Fig. 2).
We applied criteria of inductive thematic saturation to the set of
included studies, until no new optimization approaches were iden-
tified. We considered saturation to have been achieved when 10
consecutive studies did not yield any new approaches to optimiza-
tion. Data extraction was accordingly discontinued after extracting
76 articles, published in the period from November 01, 2017, to
November 06, 2019, when no new approaches to optimization
emerged from 10 consecutive studies (Fig. 3).
Characteristics of Included Studies
The majority of the 76 included articles described U.S.-based
studies (n = 48), with studies originating from Spain coming a dis-
tant second (n = 6; Fig. 4).
Optimization strategies implemented in the hospital setting
(n = 61) accounted for most included studies and ranged from
hospital-wide strategies (n = 29) and strategies encompassing
multiple wards and departments (n = 12) to highly targeted,
specialty-specific interventions (n = 20). A small number of stud-
ies were based on the optimization of ePrescribing systems in
community healthcare (n = 13). A further study was conducted
in both the hospital and community, and another was conducted
in a clinical research setting.
Of the studies providing sufficient detail, the ePrescribing land-
scape was dominated by commercial ePrescribing software sys-
tems with Epic being the most frequently reported (n = 11)
system. Many optimization strategies were reliant on the addition
of third-party software packages or apps (n = 24).
Some studies related to single optimization strategies taking
place at a very specific stage of the prescribing process. In con-
trast, other studies combined a number of optimization strategies,
working in synergy in an attempt to achieve prescribing goals and
support clinical outcomes. These can thus be viewed as multicom-
ponent interventions, using multiple technological optimization
strategies or by supplementing technological interventions with
other strategies, such as educational interventions, stakeholder en-
gagement, and organizational transformation.
Single-Component Interventions
A number of studies (n = 26) described optimization strategies,
implemented as single-component interventions (Table 2).15–40
Table 2 summarizes the various single-component optimization
strategies used in the included studies, highlighting the stage of
the ePrescribing process being optimized and the overall reported
effectiveness of the intervention on the primary outcome.
All of the single-component optimization strategies were tech-
nological interventions targeting a single step in the prescribing
process. The optimization strategies most frequently implemented
were those at the prescribing interface (n = 10), and the most fre-
quently deployed single-component optimization strategy was
CDS systems (n = 9).
Formulary Changes
In 1 study, targeting formulary changes, active pharmaceutical
ingredients in the electronic formulary of a Spanish hospital were
standardized and implemented within an oncology outpatient
clinic.15 This optimization work was associated with a decrease
in medication errors. One of the key factors in the work was the
implementation of “tall-man letters” in the electronic prescribing
system with the aim of reducing errors relating to similarly named
medications (e.g., DOBUTamine and DOPamine).
Medication Reconciliation
Medication reconciliation represents a crucial step in the pre-
scribing process for hospitalized patients that aims to reduce the
risk of iatrogenic harm through a comprehensive review of pa-
tients’ medication history. A study conducted in a hospital diabe-
tes service in Toulouse, France, used the Electronic Pharmaceutical
Record to summarize patients’ medication history, including over-
the-counter drugs, dispensed by community pharmacies over the
previous 4 months.16 By using national health insurance card de-
tails and linking to a secure Electronic Pharmaceutical Record
server, the study reported improved medication reconciliation ac-
curacy. In almost 30% of patients, medication errors that had not
previously been identified were able to be detected and rectified.
Prescribing
At the prescriber interface of ePrescribing systems, CDS,17,19–21,23,24
order sets,25 alerts,18,22 and a data dashboard26 were all deployed
as optimization strategies. Computerized decision support was of-
ten applied as an optimization strategy to aid the management of
clinical conditions with standardized treatment algorithms amena-
ble to decision support.17,19–21 Computerized decision support
was also used for broader clinical goals, such as to promote
switching of antibiotics from the intravenous to oral route to sup-
port antimicrobial stewardship,24 and for anemia management in
dialysis patients.23
Reflecting the increasing body of literature around alert fatigue,
and the risks associated with this optimization strategy, some stud-
ies attempted to optimize the existing alerts within their ePrescribing
systems.18,22 For example, Daniels et al18 sought to optimize
drug-drug interaction alerts at a pediatric hospital in Tennessee ei-
ther through suppression or by using patient-specific data from
the electronic health record to contextualize and filter alerts. The
number of interruptive drug-drug interaction alerts was reportedly
reduced by 40% for all clinicians.
Order Communications
A frequently deployed strategy was to empower pharmacists to
intercept and validate prescriptions at the order communication
stage (n = 3). Some of the studies applied this intervention as a
second check to capture errors and thereby improve the quality
and safety of prescribing,27–29 whereas a couple of the studies
used this strategy to reduce medication costs.28,30
A caveat to relying on assessment of prescriptions is the sub-
stantial volume of electronic prescriptions that are ordered through-
out hospitals on a daily basis. To tackle this issue, Jourdan et al28
used a third-party software called PHARMA to identify specific
J Patient Saf • Volume 00, Number 00, Month 2021 Optimizing Hospital Electronic Prescribing Systems
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high-risk medications or restricted usage drugs for pharmacist
review. By optimizing the pharmacist review process, the re-
search group estimated that they would have prevented 73
intensive care admission days, 74 continuous monitoring unit
hospitalization days, and 66 days of conventional hospitaliza-
tion over the 6-month study period. This equated to €5.09 of
FIGURE 2. Modified Preferred Reporting Items for Systematic Reviews and Meta-Analyses diagram.
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public health savings for every euro invested in the prescription
review activity.
Dispensing
Single-component interventions optimizing themedication dis-
pensing process were dominated by large capital expenditures in
robotics and automation, namely, automated dispensing cabinets,32
robotic dispensing technology,31,34 automated tablet dispensing and
packaging systems,35 and automated robotic compounding technol-
ogy.36 These studies mainly focused on increased efficiency and
cost savings as well as improving patient safety by reducing medi-
cation dispensing errors.
A significant reduction in dispensing errors was achieved by
implementing centralized robotic dispensing systems in hospital
pharmacies31,34 and by installing an automated tablet dispensing
and packaging system in 7 Spanish geriatric nursing homes.35
Cost savings were achieved32 at an 800-bed academic medical
center by reducing the inventory cost across 65 automated dis-
pensing cabinets. Through careful analysis and optimization of
the medications held in the automated dispensing cabinets, they
were also able to reduce the number of out of stock medications
and the number of dispenses from central pharmacy. Meanwhile,
implementing automated robotic compounding technology in a
satellite oncology pharmacy significantly decreased the turn-
around time for medications, and a return on investment within
8.6 years was projected through supply cost savings.36
Administration
To optimize medication administration, Campbell et al37 used
real-time data, extracted from the electronic health record, to warn
nurses of their individual “near-miss medication error risk” delivered
through a visual dashboard. By correlating near-miss medication
errors reported through the Barcode Medication Administration
System with environmental data related to call lights, patient
count, medication count, hours worked, sepsis scores, and task
count for a 25-bed unit, the authors performed a regression anal-
ysis to identify factors predisposing to errors on an individual
practitioner and unit-wide basis. During this pilot study, the inter-
vention reported a reduction in near-miss events.
Monitoring
Optimization strategies for monitoring prescribed medications
attempted to identify and reduce adverse drug reactions40 or
drug-drug interactions.39,40 In 1 study, CDS was combined with
pharmacogenetic data to help identify drug therapy problems in
polypharmacy patients,40 whereas in another study, 5 features of
an existing CDS were optimized to deliver patient-specific deci-
sion support for potassium-increasing drug-drug interactions.
Neither of these studies were reported as having a positive effect
on their respective primary end points. In contrast, Pereboom et al38
reported successfully using CDS to improve plasma concentration
FIGURE 3. Saturation of new approaches to optimization when
extracting data from the most recently published studies. Data
extraction was discontinued after extracting 76 articles, when it
seemed that new approaches to optimization were no longer
emerging.
FIGURE 4. Heat map of the world showing countries based on the frequency of included studies.
J Patient Saf • Volume 00, Number 00, Month 2021 Optimizing Hospital Electronic Prescribing Systems
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Williams et al J Patient Saf • Volume 00, Number 00, Month 2021











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































J Patient Saf • Volume 00, Number 00, Month 2021 Optimizing Hospital Electronic Prescribing Systems
© 2021 The Author(s). Published by Wolters Kluwer Health, Inc. www.journalpatientsafety.com 7
monitoring, thereby supporting appropriate dosing of antibiotics
with pharmacokinetic dosing rules, such as gentamicin and
vancomycin.
Multicomponent Interventions
Most studies (n = 50) reported on interventions that used more
than 1 approach to optimize ePrescribing systems (Table 3).4,41–94
Table 3 summarizes the various combinations of optimization
strategies and intervention components that were used in the in-
cluded studies and the overall reported effectiveness of the inter-
vention on the primary outcome.
Many multicomponent interventions targeted a single step in
the prescribing process, such as drug prescribing/ordering, medi-
cation administration, medication dispensing, and monitoring. In
contrast, other multicomponent interventions targeted multiple
stages in the prescribing process. In 1 study, a multifaceted ap-
proach included changes to many aspects of the CPOE system,
alongside integration of data from regional databases and substan-
tial work on culture change through education and targeted meet-
ings, involving both clinical and IT professionals.88 In other cases,
the focus of the multilevel intervention was much narrower in
scope, for example, by targeting changes in technical systems to
support barcode medicines administration.94
A multitude of optimization strategies were adopted within
these 50 multicomponent interventions. The specific components
implemented varied considerably between studies; however, these
could be broadly categorized into 4 distinct intervention strategies,
namely, technological innovations (such as installation of auto-
mated dispensing equipment), educational packages (such as for-
mal training sessions for prescribers/pharmacists), organizational/
process redesign interventions (such as formulary changes and ad-
ditional personnel procedures during the medication reconcilia-
tion process), and stakeholder engagement (consisting of
involving relevant staff in the design and adaptation of specific in-
tervention strategies). These strategies were used in different com-
binations within the identified studies.
Some form of technological innovation was deployed in every
multicomponent study. Of these, CDS was the most commonly
used technology (n = 27) often with alerts (n = 13). Although
some studies implemented alerts as an optimization strategy,
many also sought to refine and modify these to reduce alert fa-
tigue. For example, Kawamoto et al92 targeted alert fatigue by re-
fining alerts in Epic using stakeholder engagement to determine
how best to alter alert functionality. Specifically, an expert gover-
nance group was consulted and high-frequency, low-value alerts
were identified and disabled or modified. This resulted in reported
significant reductions in alerts per visit and overall alert volume
over the 3-year period from baseline to posttest. In addition, alerts
leading to a discontinuation of the triggering medication within
1 hour increased by a reported 17%. Five studies implemented a
technological intervention in conjunction with some form of
stakeholder engagement. Additional technological innovations in-
cluded barcode medication administration (BCMA, n = 8), CPOE
(n = 7), order sets (n = 7), visualization tools/data dashboards
(n = 6), smart infusion pumps (n = 4), computerized medication
reconciliation software (n = 2), and closed-loop medication sys-
tems (n = 2).
Education was a consistently implemented strategy across the
included studies, being applied in some formwithin 23 of the mul-
ticomponent interventions. Education often coincided with the
implementation/optimization of new ePrescribing technology
and focused on adequately training staff to use the new systems/
software. One study, for example, used a strategy of training clin-
ical staff, while at the same time supporting cultural change to
empower pharmacists to enforce restrictions within the prescrib-
ing process.79 Again, in some cases, the educational component
was focused on effecting organizational change, whereas, in one
example, it was provided by the ePrescribing system vendor to en-
able clinical users of the system to manage changes to the CDS.57
Eighteen studies used some form of organizational/process re-
design. As with interventions involving education or stakeholder
engagement, organizational/process redesign interventions typi-
cally accompanied some form of technological intervention.
Small-scale changes, such as pharmacist-led prescription valida-
tion procedures, comprised the majority of these studies. How-
ever, a small number of studies involved more innovative,
larger-scale interventions, such as the implementation of an anti-
microbial stewardship program,51 a closed-loop, pharmacist-led
oral chemotherapy program,84 integration of ePrescribing systems
across boundaries of care,76,88 or the addition of mandatory
free-text justification for a medication.82 Therewere also some ex-
amples of changes to organizational data governance within
existing ePrescribing systems because of the integration of data
from national and regional databases. This occurred, for example,
in the case of a national database of drug-drug interactions66 and a
state-level database of prescription drug monitoring programs.88
Relatively few studies directly measured aspects of patient
harm (such as adverse drug events or mortality; Kim, 201840;
Biltoft et al,77 2018; Gabel et al,78 2019). Instead, the majority
used surrogate outcomes as proxy measures for patient safety or
efficiency, such as medication error rates, hospital length of stay,
blood sampling or timing of medication administration, among
others (Tables 2, 3).
DISCUSSION
Principal Findings
There is now a substantial body of published work, mainly
from the United States, that has targeted a range of medication
management processes, using both relatively simple and more
complex multifaceted interventions to enhance ePrescribing sys-
tems. Technological innovations comprised the majority of the
strategies reported in the literature. However, technology-driven
interventions were also often deployed in combination with be-
havioral components, including education, stakeholder engage-
ment, and organizational change.
The fact that many studies are now focusing on refining alerts
to reduce the burden of alert fatigue reflects the potential risks that
can be introduced with digitization of prescribing processes. The
healthcare context is also an important consideration for
ePrescribing optimization strategies, with integrated healthcare
systems aiding the detection of medication overuse, errors, and in-
teractions. This is well illustrated by Jurado et al16 who used inte-
grated data from community pharmacies to help detect medication
discrepancies on admission to hospital and alsoWeiner et al88 who
developed integrated information exchange between statewide
emergency departments to counter opioid overuse. Conversely,
nonintegrated healthcare systems will undoubtedly struggle to im-
plement these optimization strategies.
Many strategies that successfully filter or contextualize data
have shown evidence of success, particularly when such strategies
focus on clinical impact, either by identifying high-risk patients or
high-risk medications.28 Some studies have demonstrated that ad-
vanced capabilities can be achieved through the optimization of
ePrescribing systems. The optimization of an ePrescribing system
was central to the development of an antimicrobial stewardship
program in an integrated healthcare system spanning many hospi-
tals, with clinical decision support, data dashboards, and
Williams et al J Patient Saf • Volume 00, Number 00, Month 2021
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development of methods to track and report antimicrobial stew-
ardship interventions. Likewise, highly integrated and contextual-
ized environmental data from a ward setting allowed Campbell
et al37 to provide real-time warnings to nursing staff about their
risk of medication administration errors through a visual dashboard.
Achieving a return on investment through ePrescribing optimi-
zation was most frequently reported in the context of medication
dispensing. Optimization with robotics and automation, whilst
representing significant investments, seem to deliver a return on
investment with quantifiable improvements to the safety and qual-
ity of the medication process.31,32,34–36
All of the single-component optimization strategies that we
identified focused on technological interventions. This is likely
to be a direct result of our search strategy and also our inclusion
and exclusion criteria. Our searches combined broad terms, such
as “quality improvement” and “audit”; however, our searches also
focused on known optimization strategies, such as “CDS” and
“alerts.” As such, to constitute optimization of an ePrescribing sys-
tem, single interventions almost always had a technological aspect
to ensure that thework was clearly relevant to ePrescribing systems.
It is also possible that some of the single optimization strategies ac-
tually had more components to the intervention than were reported
in the published study. For example, interventions may have been
implementedwith staff education; however, the educational compo-
nent may not have been fully described. Of the articles that did de-
scribe the intervention, it was generally apparent that interventions
with more components were also more likely to target multiple
stages of the prescribing process, reflecting the complexities in-
volved in optimizing numerous aspects of an ePrescribing system,
and the need for a multifaceted approach.
Multicomponent interventions were overwhelmingly imple-
mented within secondary care settings. Of these, all used either
a quasi-experimental or observational study design, finding the
intervention to be effective at optimizing the ePrescribing system
in most studies (21/24 of studies measuring objective outcomes).
Interestingly, results of multicomponent interventions within the
primary care setting were more equivocal, with only 7 of the 10
studies reporting positive findings. Furthermore, all of the studies
reporting null effects in the primary care setting were randomized
controlled trials,44,72,85 possibly indicating that bias associated
with nonrandomized and observational study designs may be in-
flating the observed effect estimates in secondary care settings.94
Inflated positive results, where randomization and blinding are
not possible, also raise the possibility of the Hawthorne effect
where subjects modify their behavior in response to being ob-
served or measured. Conversely, it may be that the primary care
setting presents barriers to the optimization of ePrescribing sys-
tems that are not present in secondary care. The primary care set-
ting often provides continuity of care, with the reconciliation and
arbitration of prescribed medications from a variety of other set-
tings. The extent of integration and data sharing between hospi-
tals, primary care, and community pharmacies within a healthcare
system will either facilitate or impede the detection of medication
errors and interactions. Where strong integration and transfer of
data exist, optimization of ePrescribing systems may not alter what
are already deemed to be well-managed patients and safe prescrib-
ing practices.44,85 However, as no formal appraisal of study quality
was undertaken (as per usual practice in scoping reviews), it cannot
be assumed that these results were not merely due to study quality
issues, and the points discussed previouslymerit further investigation.
While a scarcity of experimental research was a finding of note
in this review, so too is the abundant use of surrogate outcomes.
The use of surrogate outcomes to determine the effectiveness of
the included studies is unsurprising given the rarity of adverse
events, which lead to clinically significant harm, coupled with
the large sample sizes required to detect statistically significant
changes to this outcome. However, although outcomes, such as
medication error rates, do correlate relatively well with patient
harm, the relationship between patient harm and other outcomes,
such as efficiency of medication administration, or prescriber sat-
isfaction is less clear. Therefore, interventions reporting positive
results for such outcomes do not definitively demonstrate an im-
provement to patient safety and should be interpreted with caution.
Strengths and Limitations
By following the principles of inductive thematic saturation,13
working backward chronologically, this has allowed the scoping
review to succinctly map the most emergent and technologically
relevant optimization strategies in this diverse field of literature.
In this study, we describe a novel application of data saturation
within a scoping review. Although we have carefully linked the
concept of saturation to a central objective of the scoping review,
namely, to describe the range of approaches to optimization, we
acknowledge that by working backward through the most recently
published literature, this may have introduced bias. By reaching
saturation and only capturing the most recent optimization strate-
gies, our scoping review could be missing fundamental optimiza-
tion strategies in the ePrescribing journey that have been historically
reported.
Assessing the impact of the various optimization strategies de-
scribed in the literature is also challenging. Many studies measured
the success of their interventions by using surrogate measures with-
out addressing important clinical outcome measures. Even when
studies did consider both process and outcome measures, improv-
ing ePrescribing processes with optimization strategies did not
guarantee success in terms of clinical outcomes. For example, Fi-
gueroa et al22 successfully optimized ePrescribing alerts, resulting
in improved prescribing of low molecular weight heparin; however,
this did not have a significant impact on the incidence of venous
thromboembolic events. Vice versa, Pendharkar et al25 reduced
the length of acute hospital admissions in chronic obstructive pul-
monary disease (COPD) patients but also reported a low uptake
of the order set that was critical to their optimization strategy.
Another limitation of this scoping review is that optimization
strategies that are easy to measure or that are amenable to research
and publication will be overrepresented in the literature. This pub-
lication bias may have led to strategies that are difficult to measure
or publish not appearing in the literature. We postulate that this
may relate to some of the fundamental elements of system main-
tenance that may not be considered “worthy” of publication and
also elements of optimization that are difficult to measure such
as cyber security, software updates, and data storage and backup.
Implications for Policy, Practice, and Research
Pharmacists, clinicians, nurses, hospital management, and health
IT specialists are all key stakeholders in driving forward improve-
ments in medicine management. Consulting and working with
key stakeholderswere identified in many studies as an important fa-
cilitator in the ePrescribing optimization journey.87,88 Pharmacists,
as custodians of many of the stages within the medication use pro-
cess, are rightly reflected in the literature as playing a central role in
many of the optimization strategies encountered. Patients were,
however, notably exempt as stakeholders—an oversight that will
need to be addressed to ensure that the voices of the main benefi-
ciaries are adequately heard.
It also seems that pharmacists, doctors, and nurses use ePrescribing
systems as customizable tools to deliver localized and specialty-
specific quality improvement aims. These optimization strategies
can be powerful, achieving strong clinical buy-in and ownership,
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while also allowing ePrescribing systems and workflows to be
customized extensively to local clinical and specialty-specific
needs.81 Although localized innovation may be an effective method
to improve usability and relevance of ePrescribing systems, optimi-
zation at scale will be dependent on success stories being cascaded
and efficiently applied elsewhere. Poorly managed localized cus-
tomization has the risk of leading to increasingly divergent systems
and workflows, making policy deliberations and large-scale inter-
ventions difficult to manage. Policy-focused interventionswill need
to strike a balance between being sensitive to local needs, while
delivering interventions that can drive tangible improvements in
clinical outcome measures across large patient populations.
When extracting data, we aimed to link the optimization strat-
egies being deployed with ePrescribing systems, third-party soft-
ware, and apps. Unfortunately, the scoping review revealed a
paucity of technical data and many studies neglected to name
the ePrescribing software (n = 53) let alone describe the system
specifications and capabilities. When describing changes, im-
provements, and optimization strategies relating to ePrescribing
systems, authors should endeavor to name the software system
and the version being used. Journals could play a role in mandat-
ing minimum levels of critical information and providing authors
with appendices to document technical specifications.
CONCLUSIONS
There is now substantial knowledge on approaches to optimize
and potentially enhance the beneficial impacts of hospital
ePrescribing systems. These include targeting single or multiple
facets of the medicines management process. These approaches
can be categorized as those focusing primarily on understanding
and responding to stakeholder needs, reconceptualizing the med-
icines management process of care, technological innovations,
and educational and training packages. Simultaneously deploying
a combination of these approaches is likely to have the greatest
impact on realizing the benefits of this increasingly ubiquitous
technology.
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